menu search

Benitec biopharma inc. announces closing of $30 million underwritten public offering

HAYWARD, Calif., Aug. 11, 2023 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...

August 11, 2023, 5:00 pm

Myriad genetics (mygn) unveils genesight test enhancement

Myriad Genetics' (MYGN) GeneSight report will contain details on how a patient's smoking history may af...

August 11, 2023, 12:17 pm

Regenxbio: rgx-314 continues advancing with solid financials

REGENXBIO is a biotech company specializing in gene therapy, with a focus on addressing unmet medical needs in g...

August 10, 2023, 1:23 am

Why 23andme holding stock plummeted by 13% today

The genetics specialist notched a double miss with its latest earnings report. It seems this fiscal yea...

August 9, 2023, 5:24 pm

Benitec biopharma inc. announces pricing of $30 million underwritten public offering

HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...

August 9, 2023, 2:30 am

Genetic technologies limited (gene) q4 2023 earnings call transcript

Genetic Technologies Limited (NASDAQ:GENE ) Q4 2023 Earnings Conference Call August 8, 2023 7:15 PM ET ...

August 9, 2023, 12:11 am

Myriad genetics (mygn) posts narrower-than-estimate q2 loss

Strong testing volume improvement across all businesses drives Myriad Genetics' (MYGN) Q2 performance....

August 7, 2023, 1:38 pm

Opgen’s subsidiary ares genetics releases new features to its arescloud offering

Single nucleotide polymorphism (SNP) analysis module and interpretation of plasmids now available Added reporting customized for the needs of hospital...

August 7, 2023, 11:30 am

Fulgent genetics, inc. (flgt) reports q2 loss, tops revenue estimates

Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.08 per share versus the Zacks Consen...

August 4, 2023, 9:47 am

Myriad genetics (mygn) reports q2 loss, misses revenue estimates

Myriad Genetics (MYGN) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Est...

August 3, 2023, 8:17 pm

Myriad genetics, inc. (mygn) q2 2023 earnings call transcript

Myriad Genetics, Inc. (NASDAQ:MYGN ) Q2 2023 Results Conference Call August 3, 2023 4:30 PM ET Company ...

August 3, 2023, 7:55 pm

Omega therapeutics: working in epigenetic anti-cancer programs

OMGA has an early stage program targeting various cancers using epigenetics. They are backed by a VC an...

August 1, 2023, 4:29 pm

Passage bio welcomes dolan sondhi, ph.d. to board of directors

PHILADELPHIA, July 31, 2023 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage geneti...

July 31, 2023, 11:00 am

Fulgent genetics: post-pandemic devaluing appears overdone

Fulgent Genetics is a technology-driven company focused on clinical diagnostics and therapeutics, with ...

July 29, 2023, 2:00 pm

eneti inc. to announce second quarter 2023 results and have a conference call on august 8, 2023

MONACO, July 28, 2023 (GLOBE NEWSWIRE) — eneti Inc. (NYSE: NETI) (the “Company”) plans to announc...

July 28, 2023, 1:04 pm

eneti inc. to announce second quarter 2023 results and have a conference call on august 8, 2023

MONACO, July 28, 2023 (GLOBE NEWSWIRE) -- eneti Inc. (NYSE: NETI) (the “Company”) plans to announce...

July 28, 2023, 9:04 am

Ultragenyx to host conference call for second quarter 2023 financial results and corporate update

NOVATO, Calif., July 27, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developme...

July 27, 2023, 9:00 pm

Ultragenyx to host conference call for second quarter 2023 financial results and corporate update

NOVATO, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...

July 27, 2023, 5:00 pm

Down 97%, is it finally time to buy invitae stock?

Stock market analysts have conflicting opinions about the market value of this genetic testing business...

July 26, 2023, 5:13 am

Benitec biopharma announces 1-for-17 reverse stock split effective july 26, 2023

HAYWARD, Calif., July 25, 2023 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene the...

July 25, 2023, 5:00 pm


Search within

Pages Search Results: